Home SI-BONE Inc.


SI-BONE, Inc. Announces France’s National Healthcare System Establishes Exclusive Positive Coverage for the Triangular iFuse Implant System® for MIS SI Joint Fusion

8/27/18: Exclusive coverage based on published clinical evidence begins September 6, 2018 and extends for 5 years.

SI-BONE, Inc. Announces 23 Commercial Health Insurance Plans Now “Exclusively” Cover Triangular iFuse Implant System® Based on Published Clinical Evidence

8/7/18: "Payers continually tell us that long-term outcomes data from well-designed, well-executed randomized controlled trials are critically important when determining coverage for new procedures or technologies," said Jeffrey Dunn, President, CEO and Chairman of SI-BONE.